All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
| Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
| TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| RGEN / Repligen Corporation
|
|
|
|
|
|
|
|
| PVLA / Palvella Therapeutics, Inc.
|
|
|
|
|
|
|
|
| DNTH / Dianthus Therapeutics, Inc.
|
|
|
|
|
|
|
|
| NTRA / Natera, Inc.
|
|
|
|
|
|
|
|
| AKTS / Aktis Oncology, Inc.
|
|
|
|
|
|
|
|
| CATX / Perspective Therapeutics, Inc.
|
|
|
|
|
|
|
|
| CORT / Corcept Therapeutics Incorporated
|
|
|
|
|
|
|
|
| GMAB / Genmab A/S - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| ELVN / Enliven Therapeutics, Inc.
|
|
|
|
|
|
|
|
| VIR / Vir Biotechnology, Inc.
|
|
|
|
|
|
|
|
| ABUS / Arbutus Biopharma Corporation
|
|
|
|
|
|
|
|
| ORKA / Oruka Therapeutics, Inc.
|
|
|
|
|
|
|
|
| BBOT / BridgeBio Oncology Therapeutics, Inc.
|
|
|
|
|
|
|
|
| AVR / Anteris Technologies Global Corp.
|
|
|
|
|
|
|
|
| KPTI / Karyopharm Therapeutics Inc.
|
|
|
|
|
|
|
|
| DXCM / DexCom, Inc.
|
|
|
|
|
|
|
|
| CNTX / Context Therapeutics Inc.
|
|
|
|
|
|
|
|
| LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| MDT / Medtronic plc
|
|
|
|
|
|
|
|
| YBO0 / Tenax Therapeutics, Inc.
|
|
|
|
|
|
|
|
| GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| TEM / Tempus AI, Inc.
|
|
|
|
|
|
|
|
| ACHC / Acadia Healthcare Company, Inc.
|
|
|
|
|
|
|
|
| A / Agilent Technologies, Inc.
|
|
|
|
|
|
|
|
| ALNY / Alnylam Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| COR / Cencora, Inc.
|
|
|
|
|
|
|
|
| DHR / Danaher Corporation
|
|
|
|
|
|
|
|
| HQY / HealthEquity, Inc.
|
|
|
|
|
|
|
|
| INSM / Insmed Incorporated
|
|
|
|
|
|
|
|
| ITGR / Integer Holdings Corporation
|
|
|
|
|
|
|
|
| IQV / IQVIA Holdings Inc.
|
|
|
|
|
|
|
|
| ABT / Abbott Laboratories
|
|
|
|
|
|
|
|
| NTLA / Intellia Therapeutics, Inc.
|
|
|
|
|
|
|
|
| BSX / Boston Scientific Corporation
|
|
|
|
|
|
|
|
| BBIO / BridgeBio Pharma, Inc.
|
|
|
|
|
|
|
|
| ACAD / ACADIA Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| MLTX / MoonLake Immunotherapeutics
|
|
|
|
|
|
|
|
| SCYX / SCYNEXIS, Inc.
|
|
|
|
|
|
|
|
| HUM / Humana Inc.
|
|
|
|
|
|
|
|
| EHC / Encompass Health Corporation
|
|
|
|
|
|
|
|
| IMUX / Immunic, Inc.
|
|
|
|
|
|
|
|
| PODD / Insulet Corporation
|
|
|
|
|
|
|
|
| ICLR / ICON Public Limited Company
|
|
|
|
|
|
|
|
| SVRA / Savara Inc.
|
|
|
|
|
|
|
|
| CRL / Charles River Laboratories International, Inc.
|
|
|
|
|
|
|
|
| GILD / Gilead Sciences, Inc.
|
|
|
|
|
|
|
|
| CRVS / Corvus Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| MSLE / Satellos Bioscience Inc.
|
|
|
|
|
|
|
|
| ODD / Oddity Tech Ltd.
|
|
|
|
|
|
|
|
| PTON / Peloton Interactive, Inc.
|
|
|
|
|
|
|
|
| JBIO / Jade Biosciences, Inc.
|
|
|
|
|
|
|
|
| HIMS / Hims & Hers Health, Inc.
|
|
|
|
|
|
|
|
| MCK / McKesson Corporation
|
|
|
|
|
|
|
|
| NVO / Novo Nordisk A/S - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| PFE / Pfizer Inc.
|
|
|
|
|
|
|
|
| CI / The Cigna Group
|
|
|
|
|
|
|
|
| TMO / Thermo Fisher Scientific Inc.
|
|
|
|
|
|
|
|
| WAT / Waters Corporation
|
|
|
|
|
|
|
|
| PHAT / Phathom Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| TRVI / Trevi Therapeutics, Inc.
|
|
|
|
|
|
|
|